27.10.2014 Views

WE MAKE THINGS HAPPEN

WE MAKE THINGS HAPPEN

WE MAKE THINGS HAPPEN

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

70<br />

Hyflux Ltd annual report 2008<br />

Notes to the Financial Statements (cont’d)<br />

As at 31 December 2008<br />

2 Summary of significant accounting policies (cont’d)<br />

2.5 Intangible assets (cont’d)<br />

Research and development costs<br />

Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical knowledge<br />

and understanding, is recognised in the income statement as an expense when it is incurred.<br />

Development activities involve a plan or design for the production of new or substantially improved products<br />

and processes. Development expenditure is capitalised only if development costs can be measured reliably,<br />

the products or process is technically and commercially feasible, future economic benefits are probable, and<br />

the Group intends to and has sufficient resources to complete development and to use or sell the asset.<br />

The expenditure capitalised includes the cost of materials, direct labour and overhead costs that are directly<br />

attributable to preparing the asset for its intended use. Other development expenditure is recognised in the<br />

income statement as an expense when it is incurred.<br />

Capitalised development expenditure is stated at cost less accumulated amortisation and impairment losses.<br />

Amortisation is charged to the income statement using the straight-line method over the estimated useful lives<br />

of not more than 15 years, from the date on which they are available for use.<br />

Capitalised development expenditure that is not available for use is reviewed for impairment annually or as and<br />

when indicators of impairment are identified as described in note 2.9.<br />

Other intangible assets<br />

Other intangible assets with finite useful lives are measured at cost less accumulated amortisation and<br />

impairment losses. They are amortised in the income statement on a straight-line basis over their estimated<br />

useful lives ranging from 10 to 20 years, from the date on which they are available for use.<br />

Other intangible assets that are not available for use are tested for impairment annually or as and when indicators<br />

of impairment are identified as described in note 2.9.<br />

Subsequent expenditure<br />

Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic<br />

benefits embodied in the specific asset to which it relates. All other expenditure is expensed as incurred.<br />

2.6 Investment properties<br />

Investment properties are properties held either to earn rental income or capital appreciation or both. They do<br />

not include properties for sale in the ordinary course of business, used in the production or supply of goods or<br />

services, or for administrative purposes.<br />

Investment properties are measured at cost less accumulated depreciation and impairment losses. Rental<br />

income from investment properties is accounted for in the manner described in note 2.14.<br />

Depreciation on investment properties is recognised in the income statement on a straight-line basis over the<br />

lease terms.<br />

Depreciation methods, useful lives and residual values are reviewed, and adjusted as appropriate, at each<br />

reporting date.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!